US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
US5804396A
(en)
|
1994-10-12 |
1998-09-08 |
Sugen, Inc. |
Assay for agents active in proliferative disorders
|
AU4155696A
(en)
|
1994-11-09 |
1996-06-06 |
Regents Of The University Of California, The |
Immunoliposomes that optimize internalization into target cells
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
CA2589421C
(fr)
|
1996-03-27 |
2012-12-18 |
Genentech, Inc. |
Anticorps de la proteine erbb3
|
JP3925943B2
(ja)
|
1996-03-27 |
2007-06-06 |
ジェネンテック インコーポレーテッド |
ErbB3抗体
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
CA2258721C
(fr)
|
1996-07-12 |
2014-09-09 |
Genentech, Inc. |
Adhesines heteromultimeres chimeriques
|
US20020002276A1
(en)
|
1997-02-10 |
2002-01-03 |
Genentech, Inc. |
Chimeric heteromultimer adhesins
|
US6723694B1
(en)
|
1997-05-21 |
2004-04-20 |
The Children's Medical Center Corp. |
Short peptides which selectively modulate intracellular signalling
|
US6416168B1
(en)
|
1997-07-15 |
2002-07-09 |
Silverbrook Research Pty Ltd |
Pump action refill ink jet printing mechanism
|
US6455283B1
(en)
|
1998-03-17 |
2002-09-24 |
Genentech, Inc. |
Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
|
ZA9811162B
(en)
|
1997-12-12 |
2000-06-07 |
Genentech Inc |
Treatment with anti-ERBB2 antibodies.
|
AU2003203831B2
(en)
|
1998-02-04 |
2006-08-10 |
Genentech, Inc. |
Use of heregulin as an epithelial cell growth factor
|
EP1510579B1
(fr)
|
1998-02-04 |
2009-08-05 |
Genentech, Inc. |
Utilisation de l'héréguline comme facteur de croissance de cellule épithéliale
|
US20010023241A1
(en)
|
1998-02-04 |
2001-09-20 |
Sliwkowski Mark X. |
Use of heregulin as a growth factor
|
US6417168B1
(en)
|
1998-03-04 |
2002-07-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of treating tumors
|
DK2180007T4
(da)
|
1998-04-20 |
2017-11-27 |
Roche Glycart Ag |
Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
AU2004200705A1
(en)
|
1998-05-15 |
2004-03-18 |
Imclone Systems Incorporated |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
|
SK17282000A3
(sk)
|
1998-05-15 |
2002-04-04 |
Imclone Systems Incorporated |
Nerádioaktívne označený inhibítor proteínového tyrozínkynázového receptora
|
KR100627754B1
(ko)
|
1998-11-07 |
2006-09-26 |
제넨테크, 인크. |
Her2 및(또는) her3 수용체에 대한 리간드를 이용한내이 모 세포 증식의 향상 방법
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
EP1169352A4
(fr)
*
|
1999-04-14 |
2005-05-04 |
Smithkline Beecham Corp |
Anticorps du recepteur d'erythropoietine
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
US6710186B2
(en)
|
1999-06-14 |
2004-03-23 |
Wisconsin Alumni Research Foundation |
Oligomers and polymers of di-substituted cyclic imino carboxylic acids
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
EP2283867B1
(fr)
|
1999-06-25 |
2014-05-21 |
ImmunoGen, Inc. |
Procédés de traitement utilisant des conjugués maytansinoïdes-anticorps anti-erbb
|
CN100340575C
(zh)
|
1999-06-25 |
2007-10-03 |
杰南技术公司 |
人源化抗ErbB2抗体及其在制备药物中的应用
|
TR200200472T2
(tr)
|
1999-08-27 |
2002-06-21 |
Genentech, Inc. |
Anti-Erb B2 antikorları ile tedavi için dozajlar
|
US7390632B2
(en)
|
1999-09-30 |
2008-06-24 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
US7732157B1
(en)
|
1999-09-30 |
2010-06-08 |
Tumor Biology Investment Group |
Soluble epidermal growth factor receptor-like proteins and their uses in cancer detection methods
|
US7651703B2
(en)
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
CA2397417A1
(fr)
|
2000-01-12 |
2001-07-19 |
Sarah S. Bacus |
Methode de quantification d'une proteine par analyse d'image
|
CA2396793A1
(fr)
|
2000-02-16 |
2001-08-23 |
Genentech, Inc. |
Utilisation d'agonistes ou d'antagonistes pour moduler l'activite de molecules associees au tnf
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
US6632979B2
(en)
|
2000-03-16 |
2003-10-14 |
Genentech, Inc. |
Rodent HER2 tumor model
|
AU2007216733A1
(en)
|
2000-04-11 |
2007-09-27 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
SI2857516T1
(sl)
|
2000-04-11 |
2017-09-29 |
Genentech, Inc. |
Multivalentna protitelesa in njihove uporabe
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
AUPQ903400A0
(en)
|
2000-07-27 |
2000-08-17 |
Oh, Young June |
Navigable search engine
|
US6277640B1
(en)
|
2000-07-31 |
2001-08-21 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of Her-3 expression
|
WO2002041744A1
(fr)
|
2000-11-24 |
2002-05-30 |
Carl Freudenberg Kg |
Balai de nettoyage de sols
|
AU2008200400B2
(en)
|
2001-01-17 |
2012-06-07 |
Aptevo Research And Development Llc |
Binding domain-immunoglobulin fusion proteins
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
EP1228766A1
(fr)
|
2001-01-31 |
2002-08-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Phosphorylation de PYK2 par HER3 induit l'invasion de tumeurs
|
IL157274A0
(en)
|
2001-02-12 |
2004-02-19 |
Medarex Inc |
Human monoclonal antibodies to fc alpha receptor (cd89)
|
AU2002257132A1
(en)
|
2001-04-06 |
2002-10-21 |
The Trustees Of The University Of Pennsylvania |
Erbb interface peptidomimetics and methods of use thereof
|
WO2002087618A1
(fr)
|
2001-04-27 |
2002-11-07 |
Takeda Chemical Industries, Ltd. |
Methode de prevention et de traitement du cancer
|
EP1506399A2
(fr)
|
2001-05-21 |
2005-02-16 |
Aclara BioSciences, Inc. |
Procedes et compositions pour l'analyse de proteines
|
US7745398B2
(en)
|
2001-05-31 |
2010-06-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 and treatment of cancer
|
US7744882B2
(en)
|
2001-05-31 |
2010-06-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 methods of detection and antibodies
|
WO2002102972A2
(fr)
|
2001-06-20 |
2002-12-27 |
Prochon Biotech Ltd. |
Anticorps bloquant l'activation d'un recepteur a activite proteine tyrosine kinase, procedes de criblage et utilisations associes
|
US7276658B2
(en)
|
2001-06-21 |
2007-10-02 |
Akzo Nobel N.V. |
Manufacturing a solar cell foil connected in series via a temporary substrate
|
US7125680B2
(en)
|
2001-07-27 |
2006-10-24 |
The Regents Of The University Of California |
Methods and materials for characterizing and modulating interaction between heregulin and HER3
|
DE10137374A1
(de)
|
2001-07-31 |
2003-02-27 |
Ipk Inst Fuer Pflanzengenetik |
Verfahren zur Herstellung von Arachidonsäure in transgenen Organismen
|
AU2002326531A1
(en)
|
2001-08-03 |
2003-02-17 |
The Trustees Of The University Of Pennsylvania |
Monoclonal antibodies to activated erbb family members and methods of use thereof
|
AU2008200654B2
(en)
|
2001-08-09 |
2010-04-29 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Inhibitors of HER3 activity
|
EP1283053A1
(fr)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibiteurs de l'activité de HER3
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
JP4132912B2
(ja)
|
2002-03-26 |
2008-08-13 |
日東電工株式会社 |
ゲル電解質とその製造方法とその利用
|
EP1495123B1
(fr)
|
2002-03-26 |
2013-10-30 |
Zensun (Shanghai) Science and Technology Limited |
Procedes fondes sur l'utilisation de erbb3 et compositions associees de traitement des neoplasmes
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
US7332580B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
US20060234226A1
(en)
|
2002-04-26 |
2006-10-19 |
Fahner Robert L |
Non-affinity purification of proteins
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
US20040229380A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
US20040229299A1
(en)
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
US20040229294A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB surface receptor complexes as biomarkers
|
US20040229293A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
US20040132097A1
(en)
|
2002-06-19 |
2004-07-08 |
Bacus Sarah S. |
Method for predicting response to epidermal growth factor receptor-directed therapy
|
PT2263691E
(pt)
|
2002-07-15 |
2012-11-12 |
Hoffmann La Roche |
Tratamento de cancro com o anticorpo anti-erbb2 monoclonal humanizado recombinante 2c4 (rhumab 2c4)
|
KR20050025669A
(ko)
|
2002-07-25 |
2005-03-14 |
아클라라 바이오사이언시스 인코퍼레이티드 |
수용체 올리고머화의 검출
|
GB0225282D0
(en)
|
2002-10-31 |
2002-12-11 |
Astrazeneca Ab |
assay
|
AU2004205684A1
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
MXPA05010575A
(es)
|
2003-04-04 |
2006-03-09 |
Univ Lausanne |
Peptacuerpo para el tratamiento del cancer.
|
US7189694B2
(en)
|
2003-04-18 |
2007-03-13 |
University Of Florida Research Foundation, Inc. |
Inhibitors of autophosphorylation protein kinases
|
AU2004291709C1
(en)
|
2003-05-30 |
2010-03-11 |
Astrazeneca Uk Limited |
Process
|
DK1636593T5
(da)
|
2003-06-06 |
2009-07-27 |
Genentech Inc |
Modulering af vekselvirkningen mellem HGF-beta-kæde og c-met
|
US20050232931A1
(en)
|
2003-06-13 |
2005-10-20 |
Oncomax Acquisition Corp. |
Preparation and application of anti-tumor bifunctional fusion proteins
|
US20040254108A1
(en)
|
2003-06-13 |
2004-12-16 |
Jing Ma |
Preparation and application of anti-tumor bifunctional fusion proteins
|
WO2005001048A2
(fr)
|
2003-06-13 |
2005-01-06 |
Oncomax Acquisition Corp. |
Preparation et application de proteines hybrides bifonctionnelles anti-tumorales
|
US6836094B1
(en)
|
2003-07-01 |
2004-12-28 |
International Truck Intellectual Property Company, Llc |
Motor vehicle battery disconnect switch circuits
|
US7531649B2
(en)
|
2003-07-18 |
2009-05-12 |
The Regents Of The University Of California |
Aptamers to human epidermal growth factor receptor-3
|
SI3095793T1
(sl)
|
2003-07-28 |
2020-07-31 |
Genentech, Inc. |
Zmanjšanje izluževanja proteina A med afinitetno kromatografijo proteina A
|
US20060281093A1
(en)
|
2003-08-05 |
2006-12-14 |
Richard Kim |
Erbb receptor methods and kits for monitoring chemotherapy resistance
|
AU2004263538B2
(en)
|
2003-08-08 |
2009-09-17 |
Immunomedics, Inc. |
Bispecific antibodies for inducing apoptosis of tumor and diseased cells
|
BRPI0413471A
(pt)
|
2003-08-11 |
2006-10-17 |
Monogram Biosciences Inc |
métodos para detectar um ou mais complexos de proteìnas e para detectar um complexo em uma amostra biológica
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
US7402399B2
(en)
|
2003-10-14 |
2008-07-22 |
Monogram Biosciences, Inc. |
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
|
US20050130246A1
(en)
|
2003-10-27 |
2005-06-16 |
Hossein Salimi-Moosavi |
Detecting human anti-therapeutic antibodies
|
BRPI0416190A
(pt)
|
2003-11-06 |
2007-01-23 |
Pfizer Prod Inc |
combinações selectivas de inibidor erbb2/anticorpo anti erbb no tratamento do cancro
|
US7754441B2
(en)
|
2003-11-17 |
2010-07-13 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
CA2551813C
(fr)
|
2003-12-24 |
2014-08-12 |
Genentech, Inc. |
Compositions et methodes pour traitement des tumeurs d'origine hematopoietique
|
US8323987B2
(en)
|
2004-02-17 |
2012-12-04 |
The University Of North Carolina At Chapel Hill |
Modulation of epidermal growth factor heterodimer activity
|
US7906624B2
(en)
|
2004-02-20 |
2011-03-15 |
The Trustees Of The University Of Pennsylvania |
Binding peptidomimetics and uses of the same
|
WO2005112969A2
(fr)
|
2004-04-22 |
2005-12-01 |
Oregon Health And Science University |
Compositions et procedes pour moduler la signalisation mediee par le recepteur igf-1 et les recepteurs erbb
|
RU2433831C2
(ru)
|
2004-05-05 |
2011-11-20 |
Мерримак Фармасьютикалз, Инк. |
Биспецифические связывающие агенты для модулирования биологической активности
|
AU2005250216B2
(en)
|
2004-06-01 |
2009-12-10 |
Domantis Limited |
Bispecific fusion antibodies with enhanced serum half-life
|
GT200500155A
(es)
|
2004-06-16 |
2006-05-15 |
|
Terapia del càncer resistente al platino
|
CA2578592A1
(fr)
|
2004-06-24 |
2006-01-05 |
The Walter And Eliza Hall Institute Of Medical Research |
Conjugues et utilisations therapeutiques correspondantes
|
KR20180091967A
(ko)
|
2004-07-22 |
2018-08-16 |
제넨테크, 인크. |
Her2 항체 조성물
|
AU2005286607B2
(en)
|
2004-09-23 |
2011-01-27 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
US20080206231A1
(en)
|
2004-10-05 |
2008-08-28 |
Oregon Health And Science University |
Compositions and Methods for Treating Disease
|
EP2845865A1
(fr)
|
2004-11-12 |
2015-03-11 |
Xencor Inc. |
Variantes Fc avec liaison altérée en FcRn
|
EP1814882A1
(fr)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines et pyrazolopyrazines convenant inhibiteurs de proteines-kinases
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
US7811562B2
(en)
*
|
2004-12-03 |
2010-10-12 |
Schering Corporation |
Biomarkers for pre-selection of patients for anti-IGF1R therapy
|
WO2006063042A2
(fr)
|
2004-12-07 |
2006-06-15 |
Genentech, Inc. |
Selection de patients pour une therapie avec un inhibiteur de her
|
US7807789B2
(en)
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
EP1841882A1
(fr)
|
2004-12-21 |
2007-10-10 |
Cell Signaling Technology, Inc. |
Phosphorylation des proteines suivant des voies controlees par les egfr
|
CA2594356C
(fr)
|
2005-01-05 |
2018-07-17 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H. |
Domaines immunoglobuline synthetiques a proprietes de liaison elabores dans des regions de la molecule differentes des regions de determination de complementarite
|
JP2008527978A
(ja)
|
2005-01-11 |
2008-07-31 |
モレキュラー ロジックス,インコーポレイテッド |
Pan−HERアンタゴニストおよび使用方法
|
KR20170134771A
(ko)
|
2005-01-21 |
2017-12-06 |
제넨테크, 인크. |
Her 항체의 고정 용량 투여법
|
WO2006084018A2
(fr)
|
2005-02-02 |
2006-08-10 |
Monogram Biosciences, Inc. |
Procede permettant de determiner la sensibilite a un traitement anticancereux
|
KR101569300B1
(ko)
|
2005-02-07 |
2015-11-13 |
로슈 글리카트 아게 |
Egfr 에 결합하는 항원 결합 분자, 이를 코딩하는 벡터, 및 그의 용도
|
US7718626B2
(en)
|
2005-02-17 |
2010-05-18 |
University Of Maryland, Baltimore |
ErbB3 binding protein compositions and methods of use
|
CN101163501A
(zh)
|
2005-02-23 |
2008-04-16 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
KR101253576B1
(ko)
|
2005-02-23 |
2013-04-11 |
제넨테크, 인크. |
Her 이량체화 억제제를 이용한 암 환자에서의 질환진행까지의 시간 또는 생존의 연장
|
US7210618B2
(en)
|
2005-03-03 |
2007-05-01 |
Nokia Corporation |
Mobile communication terminal
|
JP2008535795A
(ja)
|
2005-03-07 |
2008-09-04 |
ターゲッティド・モレキュラー・ダイアグナスティクス・エルエルシー |
チロシンキナーゼインヒビター組成物、並びに疾患の治療におけるそれらの製造及び使用のための方法
|
TW200642695A
(en)
|
2005-03-08 |
2006-12-16 |
Genentech Inc |
Methods for identifying tumors responsive to treatment with her dimerization inhibitors (HDIs)
|
CA2604032C
(fr)
|
2005-04-06 |
2017-08-22 |
Ibc Pharmaceuticals, Inc. |
Methodes de generation de complexes lies stablement composes d'homodimeres, d'homotetrameres ou de dimeres de dimeres et utilisations associees
|
CA2606081C
(fr)
|
2005-04-26 |
2013-09-17 |
Markus M. Heiss |
Combinaison d'anticorps et de glucocorticoides destinee au traitement du cancer
|
US20090298061A1
(en)
|
2005-07-29 |
2009-12-03 |
Siemens Healthcare Diagnostics Inc. |
Diagnostic Methods for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapy
|
RU2482132C2
(ru)
|
2005-08-26 |
2013-05-20 |
Роше Гликарт Аг |
Модифицированные антигенсвязывающие молекулы с измененной клеточной сигнальной активностью
|
CA2624086A1
(fr)
|
2005-09-28 |
2007-04-05 |
H. Lee Moffitt Cancer Center |
Traitements anticancereux individualises
|
AU2006299429B2
(en)
|
2005-10-03 |
2012-02-23 |
Xencor, Inc. |
Fc variants with optimized Fc receptor binding properties
|
US20090252681A1
(en)
|
2005-10-11 |
2009-10-08 |
Ablynx N.V. |
Nanobodies and Polypeptides Against EGFR and IGF-IR
|
WO2007050495A2
(fr)
|
2005-10-26 |
2007-05-03 |
Children's Medical Center Corporation |
Methode permettant de pronostiquer une reponse a un anti-egfr
|
EP1792622A1
(fr)
|
2005-11-11 |
2007-06-06 |
GPC Biotech AG |
Thérapie combinée antiproliférative comprenant un agent chimiothérapeutique à base de platine et d'inhibiteurs EGFR ou d'analogues de la pyrimidine
|
SI2481753T1
(en)
|
2005-12-13 |
2018-06-29 |
Eli Lilly And Company |
Anti-IL-17 antibodies
|
EP1800695A1
(fr)
|
2005-12-21 |
2007-06-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Immuno-RNA conjugues
|
AR056857A1
(es)
*
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
US7498142B2
(en)
|
2006-01-31 |
2009-03-03 |
Yeda Research And Development Co., Ltd. |
Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
|
US20070212337A1
(en)
|
2006-02-01 |
2007-09-13 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
BRPI0709598A8
(pt)
|
2006-03-17 |
2019-01-08 |
Biogen Idec Inc |
composições de polipeptídeos estabilizados
|
WO2007115571A2
(fr)
|
2006-04-07 |
2007-10-18 |
Enkam Pharmaceuticals A/S |
Fragments peptidiques dérivés du récepteur erbb
|
US20080038271A1
(en)
|
2006-06-05 |
2008-02-14 |
Amler Lukas C |
Extending survival of cancer patients with elevated levels of EGF or TGF-alpha
|
MX2008015524A
(es)
|
2006-06-12 |
2009-01-13 |
Trubion Pharmaceuticals Inc |
Proteinas de union multivalentes monocatenarias con funcion efectora.
|
CN101627053A
(zh)
*
|
2006-06-12 |
2010-01-13 |
西福根有限公司 |
泛细胞表面受体特异的治疗剂
|
WO2007145832A2
(fr)
|
2006-06-13 |
2007-12-21 |
Shulman Zachary J |
Support de harnais POUR enfant
|
AR062223A1
(es)
|
2006-08-09 |
2008-10-22 |
Glycart Biotechnology Ag |
Moleculas de adhesion al antigeno que se adhieren a egfr, vectores que los codifican, y sus usos de estas
|
WO2008019394A2
(fr)
|
2006-08-11 |
2008-02-14 |
The Government Of The United States Of America As Represented By The Secretary, Dept Of Health And Human Services |
Méthodes de traitement et de diagnostic de troubles psychiatriques
|
US8936780B2
(en)
|
2006-08-30 |
2015-01-20 |
Advanced Cardiovascular Systems, Inc. |
Stimuli responsive polyester amide particles
|
WO2008027236A2
(fr)
|
2006-08-30 |
2008-03-06 |
Genentech, Inc. |
Anticorps multispécifiques
|
MX2009001691A
(es)
|
2006-08-31 |
2009-02-25 |
Hoffmann La Roche |
Metodo para produccion del factor de crecimiento i tipo insulina.
|
BRPI0717416A2
(pt)
|
2006-09-21 |
2013-11-12 |
Prometheus Lab Inc |
Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo
|
US20080076139A1
(en)
|
2006-09-21 |
2008-03-27 |
Sharat Singh |
Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells
|
NZ575827A
(en)
|
2006-09-21 |
2012-02-24 |
Prometheus Lab Inc |
Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
|
US20080112961A1
(en)
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
CA2668831A1
(fr)
|
2006-11-06 |
2008-06-12 |
Source Precision Medicine, Inc. |
Profilage d'expression genique pour l'identification, la surveillance et le traitement d'un melanome
|
AU2007353412A1
(en)
|
2006-11-21 |
2008-11-20 |
Fox Chase Cancer Center |
Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
|
AU2007324868B2
(en)
|
2006-11-28 |
2014-03-20 |
Daiichi Sankyo Europe Gmbh |
Activated HER3 as a marker for predicting therapeutic efficacy
|
EP2094850B1
(fr)
|
2006-12-01 |
2013-06-12 |
Agency for Science, Technology And Research |
Protéine kinases liées au cancer
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
WO2008079302A2
(fr)
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification de protéines
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
EP2121030A4
(fr)
|
2007-01-17 |
2013-06-19 |
Immunomedics Inc |
Supports polymères d'agents thérapeutiques et fractions de reconnaissance pour un ciblage à base d'anticorps de sites de maladie
|
PT2716301T
(pt)
|
2007-02-16 |
2017-07-04 |
Merrimack Pharmaceuticals Inc |
Anticorpos contra erbb3 e suas utilizações
|
EP2899541A1
(fr)
|
2007-03-02 |
2015-07-29 |
Genentech, Inc. |
Elément de prévision de la réponse à un inhibiteur de HER
|
PE20090190A1
(es)
|
2007-03-23 |
2009-03-22 |
Smithkline Beecham Corp |
Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
|
CA2681790A1
(fr)
|
2007-03-30 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Composition d'anticorps monoclonaux marques et non-marques
|
WO2008127710A2
(fr)
|
2007-04-13 |
2008-10-23 |
Dana Farber Cancer Institute |
Méthodes de traitement d'un cancer résistant à des agents thérapeutiques anti-erbb
|
FR2915115B1
(fr)
|
2007-04-23 |
2010-09-10 |
Sames Technologies |
Organe de pulverisation,dispositif de projection comportant un tel organe,installation de projection et methode de nettoyage d'un tel organe
|
NZ581703A
(en)
|
2007-06-01 |
2012-04-27 |
Univ California |
Multigene prognostic assay for lung cancer
|
KR101169243B1
(ko)
|
2007-06-06 |
2012-08-02 |
에프. 호프만-라 로슈 아게 |
종양 항원에 결합하는 비-표지된 제 1 단클론 항체 및 nir 형광 표지로 표지된 비-교차 반응성 제 2 단클론 항체로 이루어진 조성물
|
US20100183504A1
(en)
|
2007-06-14 |
2010-07-22 |
Fanqing Frank Chen |
Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
|
WO2009003082A2
(fr)
|
2007-06-26 |
2008-12-31 |
Vanderbilt University |
Compositions immunologiques utilisées en tant que biomarqueurs et/ou agents thérapeutiques pour le cancer
|
WO2009003145A1
(fr)
|
2007-06-26 |
2008-12-31 |
University Of Miami |
Protéine de fusion anticorps-endostatine et ses variants
|
PL3327026T3
(pl)
|
2007-07-09 |
2020-02-28 |
Genentech, Inc. |
Zapobieganie redukcji wiązań disiarczkowych podczas rekombinacyjnego wytwarzania polipeptydów
|
CN101802618B
(zh)
|
2007-07-13 |
2015-02-25 |
雀巢产品技术援助有限公司 |
利用基于抗体的阵列选择肺癌治疗药物
|
WO2009023266A1
(fr)
|
2007-08-14 |
2009-02-19 |
Ludwig Institute For Cancer Research |
Production d'anticorps dirigés contre des récepteurs de surface cellulaire et des protéines associées au cancer comprenant des membres de la famille des récepteurs du facteur de croissance épidermique (egfr)
|
CN108129573B
(zh)
|
2007-09-21 |
2021-10-08 |
加利福尼亚大学董事会 |
被导靶的干扰素显示强的细胞凋亡和抗肿瘤活性
|
US20110091473A1
(en)
|
2007-10-22 |
2011-04-21 |
Genmab A/S |
Novel antibody therapies
|
JP5620106B2
(ja)
|
2007-10-24 |
2014-11-05 |
株式会社糖鎖工学研究所 |
増強されたエフェクター機能を有するポリペプチド
|
NZ617520A
(en)
|
2008-02-25 |
2015-05-29 |
Nestec Sa |
Drug selection for breast cancer therapy using antibody-based arrays
|
JP2011513432A
(ja)
|
2008-03-06 |
2011-04-28 |
ジェネンテック, インコーポレイテッド |
c−met及びHERアンタゴニストの併用療法
|
EP2106806A1
(fr)
|
2008-03-31 |
2009-10-07 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Nanoparticules pour la livraison ciblée d'agents actifs vers les poumons
|
KR20110008086A
(ko)
|
2008-04-11 |
2011-01-25 |
메리맥 파마슈티컬즈, 인크. |
인간 혈청 알부민 링커 및 그 콘쥬게이트
|
US9029508B2
(en)
|
2008-04-29 |
2015-05-12 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
WO2009134870A1
(fr)
|
2008-04-30 |
2009-11-05 |
Immunogen, Inc. |
Conjugués de médicament d’agent de liaison cellulaire puissant
|
AU2009243009B2
(en)
|
2008-04-30 |
2014-09-11 |
Immunogen, Inc |
Potent conjugates and hydrophilic linkers
|
UY31800A
(es)
|
2008-05-05 |
2009-11-10 |
Smithkline Beckman Corp |
Metodo de tratamiento de cancer usando un inhibidor de cmet y axl y un inhibidor de erbb
|
BRPI0914789A2
(pt)
|
2008-06-16 |
2015-10-20 |
Immunogen Inc |
efeitos sinérgicos
|
EP2138511A1
(fr)
|
2008-06-27 |
2009-12-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
HER3 en tant que déterminant pour le pronostic de mélanome
|
JP5674654B2
(ja)
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用
|
US8445219B2
(en)
|
2008-07-25 |
2013-05-21 |
Merck Patent Gmbh |
Method of determination of receptor binding saturation effected by monoclonal antibodies
|
US8056451B2
(en)
|
2008-07-28 |
2011-11-15 |
Irwin Industrial Tool Company |
Locking pliers
|
US20100033482A1
(en)
|
2008-08-11 |
2010-02-11 |
Interactive Relighting of Dynamic Refractive Objects |
Interactive Relighting of Dynamic Refractive Objects
|
UA104868C2
(uk)
|
2008-08-15 |
2014-03-25 |
Меррімак Фармасьютікалз, Інк. |
Спосіб лікування пацієнта, що має неопластичну пухлину, відповідно до спрогнозованої реакції
|
US8084222B2
(en)
|
2008-09-26 |
2011-12-27 |
Eureka Therapeutics, Inc. |
Methods for generating host cells
|
CN102271712B
(zh)
|
2008-10-31 |
2015-11-25 |
通用医疗公司 |
用于将物质递送至生物靶标的组合物和方法
|
EP2362783A2
(fr)
|
2008-10-31 |
2011-09-07 |
Biogen Idec MA Inc. |
Molécules ciblant light et leurs utilisations
|
BRPI0921586A2
(pt)
|
2008-11-18 |
2019-09-24 |
Merrimack Pharmaceuticals Inc |
articuladores de albumina de soro humana e conjugados destes
|
US20100169729A1
(en)
|
2008-12-30 |
2010-07-01 |
Datta Shamanna M |
Enabling an integrated memory controller to transparently work with defective memory devices
|
WO2010083252A2
(fr)
|
2009-01-14 |
2010-07-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarqueurs basés sur des taux et méthodes d'utilisation associées
|
CN102439452B
(zh)
|
2009-01-15 |
2015-04-15 |
美国控股实验室公司 |
通过测量her-2表达确定患者应答的方法
|
SG172983A1
(en)
|
2009-01-15 |
2011-08-29 |
Lab Corp America Holdings |
Methods of determining patient response by measurement of her-3
|
HUE062339T2
(hu)
|
2009-02-13 |
2023-10-28 |
Immunomedics Inc |
Sejten belül hasítható kötést tartalmazó immunkonjugátumok
|
CN102326081B
(zh)
|
2009-02-24 |
2014-11-19 |
霍夫曼-拉罗奇有限公司 |
s-ErbB-3作为癌症标志物的应用
|
EP2400984A4
(fr)
|
2009-02-25 |
2013-01-23 |
Merck Sharp & Dohme |
Compositions d'anticorps anti-her2
|
AR075896A1
(es)
|
2009-03-20 |
2011-05-04 |
Genentech Inc |
Anticuerpos anti-her (factor de crecimiento epidermico)
|
AU2010242914B2
(en)
|
2009-04-29 |
2014-11-13 |
Trellis Bioscience, Llc |
Improved antibodies immunoreactive with heregulin-coupled HER3
|
SG10201507044PA
(en)
|
2009-05-29 |
2015-10-29 |
Hoffmann La Roche |
Modulators for her2 signaling in her2 expressing patients with gastric cancer
|
WO2011005481A1
(fr)
|
2009-06-22 |
2011-01-13 |
Medimmune, Llc |
Régions fc de synthèse pour une conjugaison spécifique à un site
|
AU2010273319B2
(en)
|
2009-07-15 |
2015-01-22 |
Nestec S.A. |
Drug selection for gastric cancer therapy using antibody-based arrays
|
KR101844859B1
(ko)
|
2009-08-06 |
2018-05-18 |
제넨테크, 인크. |
단백질 정제 시의 바이러스 제거의 개선방법
|
WO2011019620A1
(fr)
|
2009-08-10 |
2011-02-17 |
Genentech, Inc. |
Anticorps à fonction adcc améliorée
|
BR112012003809A2
(pt)
|
2009-08-21 |
2019-09-24 |
Merrimack Pharmaceuticals Inc |
anticorpa monoclonal isolado ou porção de ligação a antígeno do mesmo, composição e, método para tratar câncer em um indivíduo.
|
WO2011031840A1
(fr)
|
2009-09-09 |
2011-03-17 |
Quintiles Transnational Corp. |
Méthodes et compositions pour le traitement de maladies ou troubles à médiation par le récepteur tyrosine kinase
|
ES2672121T3
(es)
|
2009-10-07 |
2018-06-12 |
Macrogenics, Inc. |
Polipéptidos que contienen región Fc que presentan una función efectora mejorada debido a alteraciones del grado de fucosilación, y métodos para su uso
|
WO2011044311A2
(fr)
|
2009-10-09 |
2011-04-14 |
Merck Sharp & Dohme Corp. |
Génération, caractérisation et utilisations d'anticorps anti-her3
|
CA2777242A1
(fr)
|
2009-10-14 |
2011-04-21 |
Merrimack Pharmaceuticals, Inc. |
Agents de liaison bispecifiques qui ciblent la signalisation igf-1r et erbb3, et leurs utilisations
|
PT3351558T
(pt)
|
2009-11-13 |
2020-04-09 |
Daiichi Sankyo Europe Gmbh |
Material e métodos para tratamento ou prevenção de doenças associadas a her-3
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
US20130225424A1
(en)
|
2010-03-03 |
2013-08-29 |
Targeted Molecular Diagnostics, Llc |
Methods for determining responsiveness to a drug based upon determination of ras mutation and/or ras amplification
|
US8895001B2
(en)
|
2010-03-11 |
2014-11-25 |
Merrimack Pharmaceuticals, Inc. |
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
|
ES2566602T3
(es)
|
2010-04-09 |
2016-04-14 |
Aveo Pharmaceuticals, Inc. |
Anticuerpos anti-ErbB3
|
WO2011139629A2
(fr)
|
2010-04-26 |
2011-11-10 |
Biogen Idec Ma Inc. |
Molécules ciblant light et ses utilisations
|
CA2799217A1
(fr)
|
2010-05-13 |
2011-11-17 |
Fox Chase Cancer Center |
Recombinantly produced antibodies targeting erbb signaling molecules and methods of use thereof for the diagnosis and treatment of disease
|
WO2011146568A1
(fr)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Prédiction de réponses à un inhibiteur de her
|
NZ603570A
(en)
|
2010-05-20 |
2014-12-24 |
Ablynx Nv |
Biological materials related to her3
|
AU2012211258A1
(en)
|
2011-01-27 |
2013-03-21 |
Merrimack Pharmaceuticals, Inc. |
Treatment of advanced solid stage tumors using anti-ErbB3 antibodies
|
WO2012106578A1
(fr)
|
2011-02-04 |
2012-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticorps neutralisant le vih, présentant des mutations dans le domaine constant (fc)
|
WO2012106587A1
(fr)
|
2011-02-04 |
2012-08-09 |
Genentech, Inc. |
Variantes génétiques de fc et leurs procédés de production
|
EP2673299B1
(fr)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Polypeptides fc modifiés d'immunoglobuline
|
US9574003B2
(en)
|
2011-03-06 |
2017-02-21 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
CA2830501C
(fr)
|
2011-03-17 |
2023-10-17 |
Cernostics, Inc. |
Systemes et compositions pour le diagnostic de l'oesophage de barrett et leurs procedes d'utilisation
|